Pages that link to "Q72900133"
Jump to navigation
Jump to search
The following pages link to Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis (Q72900133):
Displaying 9 items.
- Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age (Q24245934) (← links)
- Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin (Q33598839) (← links)
- Cefaclor revisited (Q33879262) (← links)
- Macrolides: A Canadian Infectious Disease Society position paper (Q36170393) (← links)
- Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients (Q37882764) (← links)
- Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection (Q39419017) (← links)
- An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacteri (Q42694628) (← links)
- Comparison of once- and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infections (Q43868195) (← links)
- Antibiotic prescribing for bronchitis: time for a change? (Q72531287) (← links)